AbbVie (ABBV) Stock Highlights

175.58 | +2.37%

2024-12-21 00:02:34

AbbVie is a pharmaceutical company with a strong exposure to immunology and oncology. The firms top drug, Humira, represents close to half of the companys current profits. The company was spun off from Abbott in early 2013. The recent acquisition of Allergan adds several new drugs in aesthetics and womens health.

Statistics

Range Today

170.66 176.8

Volume Today 5.83M

Range 1 Year

151.29 207.32

Volume 1 Year 1.39B

Range 3 Year

128.23 207.32

Volume 3 Year 4.41B

Range 10 Year

45.45 207.32

Volume 10 Year 18.43B

Highlights

Market Capitalization 310.27B (mega)

Floating Shares 1.76B

Current Price 175.58

Price To Earnings 60.07

Price To Revenue 6.61

Price To Book 51.44

Earnings Per Share 2.86

Dividend Yield 3.82%

Dividend Per Share 6.56

Payout Ratio 213.59%

Performance

Latest +2.37%

1 Month +5.19%

3 Months -9.03%

6 Months +2.57%

1 Year +14.02%

3 Years +36.63%

5 Years +94.23%

10 Years +158.05%

Benchmarks

Market Capitalization

4 / 14

Gross Profits

4 / 14

Total Revenue

4 / 14

Total Rank

7 / 14

Free Cashflow

1 / 14

Performance 5 years

2 / 14

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.